2m 2m 2m 2m 2m 2m 2m
ENVISTA HLDG (NVST)
NYSE
$25.27+$0.005 (+0.02%)
Price as of Jun 23, 2026 5:33 PM EDT- $4.2BMarket Cap
- 33.37%1-Year Change
- Medical Instruments & SuppliesIndustry
ENVISTA HLDG (NVST)
$25.27+$0.005 (+0.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.7B +8.32% | 2.5B -2.18% | 2.6B -0.10% | 2.6B +2.40% | |
Cost of Revenue | 1.2B +8.34% | 1.1B +1.06% | 1.1B +2.90% | 1.1B +1.10% | |
Gross Profit | 1.5B +8.30% | 1.4B -4.71% | 1.4B -2.33% | 1.5B +3.39% | |
Sales and Marketing Expense | 1.2B -0.12% | 1.2B +9.57% | 1.1B +0.13% | 1.1B +3.50% | |
Research and Development Expense | -114.0M +15.04% | -99.1M +5.65% | -93.8M -193.71% | 100.1M -0.40% | |
Depreciation and Amortization Expense | 40.1M -1.72% | 40.8M +13.33% | 36.0M +13.21% | 31.8M -22.06% | |
Total Operating Expenses | 1.2B +8.34% | 1.1B +1.06% | 1.1B +2.90% | 1.1B +1.10% | |
Operating Profit | 216.1M +120.81% | -1.0B -3,395.87% | 31.5M -90.13% | 319.2M +4.25% | |
Interest Income | -6.2M +1,450.00% | -400,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | -36.6M -21.12% | -46.4M -26.81% | -63.4M +65.10% | -38.4M -29.02% | |
Interest Income and Expense and Net | -42.8M -8.55% | -46.8M -26.18% | -63.4M -265.10% | 38.4M -29.02% | |
Total Nonoperating Income and Expense | -2.3M +2,200.00% | -100,000 -99.57% | -23.0M -841.94% | 3.1M +29.17% | |
Income before Taxes | 177.2M +116.34% | -1.1B +1,875.77% | -54.9M -119.34% | 283.9M +11.55% | |
Income Taxes | 130.2M +284.07% | 33.9M -25.17% | 45.3M -1.31% | 45.9M +610.00% | |
Extraordinary Items | N/A N/A | N/A N/A | 4.8M 0.00% | 4.8M -74.74% | |
Net Income | 47.0M +104.20% | -1.1B +1,016.37% | -100.2M -141.22% | 243.1M -28.60% | |
Net Income from Continuing Operations Applicable to Common | 177.2M +115.84% | -1.1B +1,016.37% | -100.2M -142.10% | 238.0M -9.68% | |
Basic EPS and Net Income | 0.28 +104.31% | -6.50 +983.33% | -0.60 -140.27% | 1.49 -29.38% | |
Diluted EPS and Net Income | 0.28 +104.31% | -6.50 +983.33% | -0.60 -143.80% | 1.37 -28.65% | |
Basic Weighted Average Shares | 168.0M -2.44% | 172.2M +3.18% | 166.9M +2.46% | 162.9M +1.05% | |
Diluted Weighted Average Shares | 169.2M -1.74% | 172.2M +3.18% | 166.9M -6.02% | 177.6M 0.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.2B +13.34% | 1.1B +13.73% | 940.0M +54.89% | 606.9M -43.47% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.2B +13.34% | 1.1B +13.73% | 940.0M +54.89% | 606.9M -43.47% | |
Total Current Assets | 2.0B +13.33% | 1.8B +2.56% | 1.7B +22.40% | 1.4B -22.40% | |
Accumulated Depreciation | 407.7M +11.97% | 364.1M +6.77% | 341.0M +9.19% | 312.3M -0.98% | |
Property and Plant and Equipment and Net | 296.8M +7.15% | 277.0M -10.53% | 309.6M +5.45% | 293.6M +11.17% | |
Total Long-Term Assets | 228.1M -1.08% | 230.6M +27.76% | 180.5M +17.44% | 153.7M -8.40% | |
Total Assets | 5.7B +6.14% | 5.4B -18.99% | 6.6B +0.27% | 6.6B +0.19% | |
Income Taxes Payable | 96.5M +26.14% | 76.5M +16.62% | 65.6M -28.77% | 92.1M -63.09% | |
Total Short-Term Debt | 0 -100.00% | 116.0M +0.61% | 115.3M -77.39% | 510.0M +17.95% | |
Total Current Liabilities | 852.6M -2.97% | 878.7M +12.54% | 780.8M -36.86% | 1.2B +2.36% | |
Total Long-Term Debt | 1.4B +13.30% | 1.3B -8.57% | 1.4B +60.57% | 870.7M -1.44% | |
Total Long-Term Liabilities | 161.4M +15.45% | 139.8M -1.83% | 142.4M -5.88% | 151.3M -50.26% | |
Total Liabilities | 963.0M -3.47% | 997.6M +12.00% | 890.7M -34.42% | 1.4B +2.22% | |
Retained Earnings | -440.4M -9.64% | -487.4M -177.22% | 631.2M -13.70% | 731.4M +56.65% | |
Total Stockholders Equity | 3.1B +5.84% | 2.9B -29.69% | 4.2B -0.78% | 4.2B +3.68% | |
Total Shares Outstanding | 163.8M -4.88% | 172.2M +0.41% | 171.5M +5.09% | 163.2M +0.99% | |
Cash Flow | |||||
Cash from Operating Activities | 275.7M -18.07% | 336.5M +22.05% | 275.7M +50.90% | 182.7M -49.47% | |
Capital Expenditures | 45.3M +34.02% | 33.8M -41.92% | 58.2M -23.12% | 75.7M +38.39% | |
Cash from Investing Activities | -51.1M -6.41% | -54.6M -12.50% | -62.4M -90.51% | -657.3M -350.21% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -170.9M +64.80% | -103.7M -187.22% | 118.9M +851.20% | 12.5M +102.68% | |
Financials Ratio | |||||
Gross Margin | 54.67% -0.01% | 54.68% -2.58% | 56.13% -2.23% | 57.41% +0.96% | |
Operating Margin | 7.95% +119.22% | -41.35% -3,469.13% | 1.23% -90.12% | 12.42% +1.80% | |
Return on Assets | 0.85% +104.55% | -18.71% +1,131.82% | -1.52% -141.12% | 3.69% -27.04% | |
Return on Equity | 1.56% +104.94% | -31.47% +1,216.13% | -2.39% -140.65% | 5.88% -32.81% | |
Revenue Growth | 8.32% +482.02% | -2.18% +2,052.27% | -0.10% -104.22% | 2.40% -75.87% | |
Current Ratio | 2.38 +16.79% | 2.04 -8.87% | 2.23 +93.87% | 1.15 -24.19% | |
Cash Ratio | 1.42 +16.81% | 1.22 +1.06% | 1.20 +145.34% | 0.49 -44.78% | |
Debt-to-Equity Ratio | 0.47 -1.87% | 0.48 +31.03% | 0.36 +10.48% | 0.33 +1.20% | |
Debt-to-Assets Ratio | 0.26 -2.15% | 0.26 +13.75% | 0.23 +9.30% | 0.21 +4.75% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow